Bessemer Group
AIMT

Bessemer Group’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Bessemer Group’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,700
Closed -$62K – 1800
2020
Q2 		$62K Buy
+3,700
New +$62K ﹤0.01% 1319